DK25992D0 - Quinolinderivater, deres fremstilling samt farmaeutisk praeparat indeholdende saadanne derivater - Google Patents

Quinolinderivater, deres fremstilling samt farmaeutisk praeparat indeholdende saadanne derivater

Info

Publication number
DK25992D0
DK25992D0 DK92259A DK25992A DK25992D0 DK 25992 D0 DK25992 D0 DK 25992D0 DK 92259 A DK92259 A DK 92259A DK 25992 A DK25992 A DK 25992A DK 25992 D0 DK25992 D0 DK 25992D0
Authority
DK
Denmark
Prior art keywords
derivatives
preparation
quinoline
pharmaceutical preparation
pharmaceutical
Prior art date
Application number
DK92259A
Other languages
English (en)
Other versions
DK170774B1 (da
DK25992A (da
Inventor
Jun-Ichi Matsumoto
Teruyuki Miyamoto
Hiroshi Egawa
Shinichi Nakamura
Original Assignee
Dainippon Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Pharmaceutical Co filed Critical Dainippon Pharmaceutical Co
Publication of DK25992D0 publication Critical patent/DK25992D0/da
Publication of DK25992A publication Critical patent/DK25992A/da
Application granted granted Critical
Publication of DK170774B1 publication Critical patent/DK170774B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK025992A 1985-10-29 1992-02-28 1-Cyclopropyl-5,6,8-trifluor-7-(3-methyl-1-piperazinyl)-1,4-dihydro-4-oxoquinolin-3-carboxylsyrer, deres fremstilling samt farmaceutisk præparat indeholdende sådanne forbindelser DK170774B1 (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP24225785 1985-10-29
JP24225785 1985-10-29
JP28532385 1985-12-17
JP28532385 1985-12-17
JP3262786 1986-02-17
JP3262786 1986-02-17

Publications (3)

Publication Number Publication Date
DK25992D0 true DK25992D0 (da) 1992-02-28
DK25992A DK25992A (da) 1992-02-28
DK170774B1 DK170774B1 (da) 1996-01-15

Family

ID=27287785

Family Applications (2)

Application Number Title Priority Date Filing Date
DK514586A DK170593B1 (da) 1985-10-29 1986-10-28 1-Cyclopropyl-5-amino-6,8-difluor-7-piperazinyl-1,4-dihydro-4-oxo-quinolin-3-carboxylsyre-derivater, deres fremstilling og farmaceutisk præparat indeholdende disse derivater
DK025992A DK170774B1 (da) 1985-10-29 1992-02-28 1-Cyclopropyl-5,6,8-trifluor-7-(3-methyl-1-piperazinyl)-1,4-dihydro-4-oxoquinolin-3-carboxylsyrer, deres fremstilling samt farmaceutisk præparat indeholdende sådanne forbindelser

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK514586A DK170593B1 (da) 1985-10-29 1986-10-28 1-Cyclopropyl-5-amino-6,8-difluor-7-piperazinyl-1,4-dihydro-4-oxo-quinolin-3-carboxylsyre-derivater, deres fremstilling og farmaceutisk præparat indeholdende disse derivater

Country Status (26)

Country Link
US (1) US4795751A (da)
EP (2) EP0221463B1 (da)
JP (2) JPS62277362A (da)
KR (1) KR910006806B1 (da)
CN (1) CN1009930B (da)
AR (3) AR242031A1 (da)
AT (2) ATE66210T1 (da)
AU (1) AU594983B2 (da)
CA (1) CA1340402C (da)
DE (3) DE3680859D1 (da)
DK (2) DK170593B1 (da)
ES (2) ES2029786T3 (da)
FI (1) FI87457C (da)
GE (1) GEP19960467B (da)
GR (1) GR3002475T3 (da)
HU (1) HU200452B (da)
IL (1) IL80404A (da)
LU (2) LU88596I2 (da)
MY (1) MY100574A (da)
NL (2) NL970020I2 (da)
NO (1) NO170726C (da)
NZ (1) NZ218089A (da)
PH (1) PH22862A (da)
PT (1) PT83643B (da)
SU (2) SU1635898A3 (da)
YU (3) YU46414B (da)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4977154A (en) * 1985-12-12 1990-12-11 Warner-Lambert Company 5-amino and 5-hydroxy-6-fluoroquinolones as antibacterial agents
EP0242789A3 (en) * 1986-04-25 1990-09-05 Dainippon Pharmaceutical Co., Ltd. Novel quinoline derivates and processes for preparation thereof
DE3711193A1 (de) * 1987-04-02 1988-10-13 Bayer Ag 5-substituierte chinolon- und naphthyridoncarbonsaeure-derivate
US5591744A (en) * 1987-04-16 1997-01-07 Otsuka Pharmaceutical Company, Limited Benzoheterocyclic compounds
US4780468A (en) * 1987-08-07 1988-10-25 Warner-Lambert Company 8-trifluoromethyl quinolones as antibacterial agents
US5164392A (en) * 1987-10-16 1992-11-17 Dainippon Pharmaceutical Co., Ltd. Quinoline derivatives and antibacterial agent containing them
IL88003A (en) * 1987-10-16 1992-11-15 Dainippon Pharmaceutical Co Quinoline derivatives,their preparation and pharmaceutical compositions containing them
AU609974B2 (en) * 1988-05-18 1991-05-09 Warner-Lambert Company Improved process for the preparation of 5-amino-7- (substituted amino)-quinoline-3-carboxylic acids
JPH0674261B2 (ja) * 1988-06-21 1994-09-21 塩野義製薬株式会社 キノロンカルボン酸誘導体
JP2709604B2 (ja) * 1988-06-29 1998-02-04 大日本製薬株式会社 マイコプラズマ汚染の防止または除去
US5262417A (en) * 1988-12-06 1993-11-16 The Upjohn Company Antibacterial quinolone compounds
FR2655545B1 (fr) 1989-12-11 1994-06-10 Rhone Poulenc Sante Nouvelle application therapeutique des derives des fluoroquinolones.
DE4019023A1 (de) * 1990-06-14 1991-12-19 Bayer Ag Verfahren zur herstellung von chinolincarbonsaeuren
JP2613139B2 (ja) * 1990-07-19 1997-05-21 エスエス製薬 株式会社 キノロンカルボン酸誘導体
US5342846A (en) * 1990-12-05 1994-08-30 Synphar Laboratories, Inc. 7-substituted-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid compounds and 7-(substituted triazolyl pyrrolidin-1-yl) 4-oxoquinoline-3-carboxylic acid derivatives useful as antibacterial agents
FR2681863B1 (fr) * 1991-09-27 1995-02-03 Rhone Dpc Europ Solution de sparfloxacine sa preparation et sel la constituant.
WO1993024460A1 (fr) * 1992-05-26 1993-12-09 Ss Pharmaceutical Co., Ltd. Derive d'acides-5-aminoquinolonecarboxylique et agent antibacterien contenant ce derive comme ingredient actif
WO1993025545A1 (en) * 1992-06-09 1993-12-23 Korea Research Institute Of Chemical Technology Novel quinoline derivatives and processes for preparing the same
US5290794A (en) * 1992-10-27 1994-03-01 Warner Lambert Co. Soluble calcium lactate antibacterial complexes as non-irritating parenteral forms
US5646163A (en) * 1992-10-30 1997-07-08 The Procter & Gamble Company Quinolone 5-(N-heterosubstituted amino) antimicrobials
CN1038326C (zh) * 1993-07-20 1998-05-13 爱斯制药株式会社 5－氨基喹诺酮羧酸衍生物及其含有该衍生物作为活性成分的抗菌剂
US5532239A (en) * 1993-08-02 1996-07-02 Assistance Publique - Hopitaux De Paris Therapeutic application of fluoroquinolone derivatives
JP2003527308A (ja) 1998-12-04 2003-09-16 インフラックス，インコーポレイテッド 多剤輸送体の阻害剤
AU3192700A (en) 1999-03-17 2000-10-04 Daiichi Pharmaceutical Co., Ltd. Medicinal compositions
CN1091103C (zh) * 1999-04-02 2002-09-18 中国科学院上海药物研究所 一类喹诺酮类化合物及它的制备和其用途
US6957105B2 (en) * 2002-03-26 2005-10-18 Cardiac Pacemakers, Inc. Method and apparatus for detecting oscillations in cardiac rhythm with electrogram signals
KR100519158B1 (ko) * 2002-12-21 2005-10-06 주식회사유한양행 퀴놀론 카르복실레이트 유도체의 제조방법
US20070197548A1 (en) 2006-02-17 2007-08-23 Murthy Yerramilli V S Fluoroquinolone compositions
US20070196398A1 (en) * 2006-02-17 2007-08-23 Murthy Yerramilli V S Fluoroquinolone fatty acid salt compositions
US7973022B2 (en) 2006-02-17 2011-07-05 Idexx Laboratories, Inc. Fluoroquinolone carboxylic acid salt compositions
US20080139574A1 (en) 2006-11-30 2008-06-12 Cadila Healthcare Limited Novel quinoline derivatives
US20200215074A1 (en) 2017-06-22 2020-07-09 Cipla Limited Method of Treatment of Cancer
CN110724097B (zh) * 2019-11-11 2021-03-09 山东畜牧兽医职业学院 一种治疗耐药性微生物菌的化合物及其制备方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3753993A (en) * 1971-05-17 1973-08-21 Sterling Drug Inc 1,4-dihydro-4-oxo-7-pyridyl-3-quinoline-carboxylic acid derivatives
DE3033157A1 (de) * 1980-09-03 1982-04-01 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-naphthyridin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
JPS58174367A (ja) 1982-04-07 1983-10-13 Tanabe Seiyaku Co Ltd キノリン誘導体及びその製法
DE3248506A1 (de) * 1982-12-29 1984-07-05 Bayer Ag, 5090 Leverkusen 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7(alkyl-1-piperazinyl)-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3248507A1 (de) * 1982-12-29 1984-07-05 Bayer Ag, 5090 Leverkusen Mikrobizide mittel auf chinoloncarbonsaeure basis
DE3306771A1 (de) * 1983-02-25 1984-08-30 Bayer Ag, 5090 Leverkusen Chinoloncarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3318145A1 (de) * 1983-05-18 1984-11-22 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-6,8-difluor-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
CS274601B2 (en) * 1983-07-27 1991-09-15 Dainippon Pharmaceutical Co Method of 1,8-naphthyridine derivative production
JPS60169475A (ja) * 1984-02-14 1985-09-02 Dai Ichi Seiyaku Co Ltd キノリン誘導体
EP0160578B1 (en) * 1984-02-17 1989-11-23 Daiichi Seiyaku Co., Ltd. 1,8-naphthyridine derivatives
US4571396A (en) * 1984-04-16 1986-02-18 Warner-Lambert Company Antibacterial agents
ZA852369B (en) 1984-04-26 1985-12-24 Abbott Lab Quinoline antibacterial compounds
DE3420743A1 (de) * 1984-06-04 1985-12-05 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-6,8-dihalogen-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3420798A1 (de) * 1984-06-04 1985-12-05 Bayer Ag, 5090 Leverkusen 7-(3-aryl-l-piperazinyl)- sowie 7-(3-cyclohexyl-l-piperazinyl)-3-chinoloncarbonsaeuren
JPS6110574A (ja) * 1984-06-25 1986-01-18 Hokuriku Seiyaku Co Ltd ６−フルオロ−１，４−ジヒドロ−４−オキソ−７−置換ピペラジニルキノリン−３−カルボン酸誘導体
IE58742B1 (en) 1984-07-20 1993-11-05 Warner Lambert Co Substituted-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7h-pyrido[1,2,3-de] [1,4]benzoxauine-6-carboxylic acids; sibstituted-5-amino-6-6fluoro-4-oxo.1,4-dihydroquinoline-3 carboxylic acids; substituted-5-amino-6-fluoro-1,4-dihydro-4-oxo-1.8-naphthyridine-3-carboxylic acids; derivatives thereof; pharmaceutical compositions comprising the compounds; and processes for producing the compounds
JPS6191183A (ja) * 1984-10-11 1986-05-09 Kyorin Pharmaceut Co Ltd キノロンカルボン酸誘導体
EP0181521A1 (en) * 1984-10-19 1986-05-21 Otsuka Pharmaceutical Co., Ltd. Antimicrobial 1-substituted Phenyl-4-oxoquinoline-3-carboxylic acid compounds
US4636506A (en) * 1984-12-06 1987-01-13 Pfizer, Inc. 7-heterocyclic-1,4-dihydroquinolones
EP0191185B1 (en) * 1984-12-14 1990-03-07 Daiichi Seiyaku Co., Ltd. Quinoline-carboxylic acid derivatives
US4657913A (en) * 1985-04-18 1987-04-14 Warner-Lambert Company Trifluoro- quinoline -3- carboxylic acids and their use as anti-bacterial agents
JPS6259263A (ja) * 1985-09-10 1987-03-14 Kyorin Pharmaceut Co Ltd キノロンカルボン酸誘導体
US4977154A (en) * 1985-12-12 1990-12-11 Warner-Lambert Company 5-amino and 5-hydroxy-6-fluoroquinolones as antibacterial agents
US4668680A (en) * 1985-12-12 1987-05-26 Warner-Lambert Company 5-amino-6,8-difluoroquinolones as antibacterial agents
EP0230053A3 (en) * 1986-01-17 1988-03-30 American Cyanamid Company 7-(substituted)piperazinyl-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids
EP0242789A3 (en) * 1986-04-25 1990-09-05 Dainippon Pharmaceutical Co., Ltd. Novel quinoline derivates and processes for preparation thereof
GB8612137D0 (en) * 1986-05-19 1986-06-25 Fujisawa Pharmaceutical Co Quinolone compounds

Also Published As

Publication number Publication date
DE10075028I1 (de) 2000-12-14
MY100574A (en) 1990-12-15
CN1009930B (zh) 1990-10-10
FI87457C (fi) 1993-01-11
EP0375658B1 (en) 1994-08-03
EP0375658A1 (en) 1990-06-27
JPH0714918B2 (ja) 1995-02-22
US4795751A (en) 1989-01-03
DE10075028I2 (de) 2004-01-29
IL80404A0 (en) 1987-01-30
KR910006806B1 (ko) 1991-09-02
NL300014I2 (nl) 2001-02-01
AU6427786A (en) 1987-04-30
NO170726C (no) 1992-11-25
DE3680859D1 (de) 1991-09-19
FI87457B (fi) 1992-09-30
YU46414B (sh) 1993-10-20
AR243520A1 (es) 1993-08-31
DK514586D0 (da) 1986-10-28
DK170593B1 (da) 1995-11-06
EP0221463B1 (en) 1991-08-14
DE3650018T2 (de) 1995-01-05
KR870004019A (ko) 1987-05-06
PT83643A (en) 1986-11-01
EP0221463A2 (en) 1987-05-13
DE3650018D1 (de) 1994-09-08
LU88596I2 (fr) 1995-07-10
NO864247D0 (no) 1986-10-23
CN86107491A (zh) 1987-04-29
IL80404A (en) 1990-06-10
FI864299A0 (fi) 1986-10-23
DK170774B1 (da) 1996-01-15
ATE66210T1 (de) 1991-08-15
JPH0543551A (ja) 1993-02-23
JPS62277362A (ja) 1987-12-02
ATE109472T1 (de) 1994-08-15
CA1340402C (en) 1999-02-23
PH22862A (en) 1989-01-19
HUT43839A (en) 1987-12-28
SU1598873A3 (ru) 1990-10-07
PT83643B (pt) 1988-10-14
ES2057197T3 (es) 1994-10-16
NO864247L (no) 1987-04-30
NL970020I2 (nl) 1998-01-05
AR243178A1 (es) 1993-07-30
LU90621I2 (fr) 2000-10-09
GEP19960467B (en) 1996-05-27
NL300014I1 (nl) 2000-10-02
NZ218089A (en) 1989-03-29
YU183586A (en) 1988-04-30
DK514586A (da) 1987-04-30
JPH0541633B2 (da) 1993-06-24
DK25992A (da) 1992-02-28
EP0221463A3 (en) 1987-12-02
HU200452B (en) 1990-06-28
FI864299A (fi) 1987-04-30
GR3002475T3 (en) 1992-12-30
SU1635898A3 (ru) 1991-03-15
NO170726B (no) 1992-08-17
NL970020I1 (nl) 1997-08-01
YU137191A (sh) 1994-01-20
AR242031A1 (es) 1993-02-26
YU137291A (sh) 1994-01-20
ES2029786T3 (es) 1992-10-01
AU594983B2 (en) 1990-03-22

Similar Documents

Publication Publication Date Title
DK25992D0 (da) Quinolinderivater, deres fremstilling samt farmaeutisk praeparat indeholdende saadanne derivater
DK289886A (da) Substituerede 3-phenyl-4-cyanopyrrol-derivater samt deres fremstilling og anvendelse
DK165249C (da) Imidazooe4,5-baaquinolin-2-thionderivater samt fremgangsmaade til fremstilling deraf
DK260386A (da) Pyrimidinderivater samt deres anvendelse som laegemidler
DK52388A (da) Polyaminderivater samt fremgangsmaader til deres fremstilling
DK259186A (da) Nasale farmaceutiske praeparater
DK165635C (da) 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-1,8-naphthyridin-3-carboxy-derivater, farmaceutisk praeparat omfattende saadanne forbindelser, samt fremgangsmaade til fremstilling af forbindelserne
DK408186D0 (da) Podophyllotoxin og derivater deraf, fremgangsmaader til deres fremstilling og anvendelse samt farmaceutiske praeparater indeholdende forbindelserne
DK29686D0 (da) 13beta-alkyl-milbemycinderivater samt deres fremstilling og anvendelse
DK163584C (da) 7-amino-3-propenylcephalosporinsyrederivater samt fremgangsmaade til fremstilling deraf
DK465686A (da) Pyridinylderivater samt deres fremstilling og anvendelse
DK618886D0 (da) 6,7,8,9-tetrahydro-10-methylpyrido-(1,2-a)-indol-9-aminer og derivater deraf, samt deres fremstilling og anvendelse
DK143188A (da) Farmaceutiske praeparater indeholdende pyranoquinolinforbindelser samt deres anvendelse
DK162186A (da) Aminoketonderivater samt laegemidler indeholdende saadanne derivater
DK548086D0 (da) Nitroanthracycliner, fremgangsmaade til deres fremstilling samt deres anvendelse
DK449989D0 (da) Quinolinderivater, deres fremstilling og laegemidler indeholdende disse derivater
DK162092C (da) Basisk substituerede 3-phenyl-quinolin-2-on-derivater, deres fremstilling og anvendelse samt laegemiddel indeholdende disse derivater
DK77186D0 (da) 1,4,6-tri-0-acylerede hexosederivater samt deres fremstilling og anvendelse
DK287487D0 (da) 4-phenyl-4-oxo-2-butensyrederivater, deres fremstilling samt laegemidler med indhold deraf
DK406486A (da) Hydropyridinderivater samt deres fremstilling og anvendelse
DK527886D0 (da) 2,3,4,6-tetrasubstituerede 1,4-dihydropyridin-5-carboxylsyrederivater samt deres fremstilling og anvendelse
DK386086D0 (da) Substituerede 1,4-dihydro-pyridinderivater samt deres fremstilling og anvendelse
DK402585A (da) Pseudooligosaccharider med alfa-glucosidase-inhiberende virkning, deres fremstilling og anvendelse samt farmaceutiske praeparater
DK52186D0 (da) Farmaceutisk praeparat indeholdende indolderivater
DK77286D0 (da) 1-0-acylerede hexosederivater samt deres fremstilling og anvendelse

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired